Calithera Biosciences Inc (CALA)
0.02
-0.01
(-31.03%)
USD |
OTCM |
Apr 24, 16:00
Calithera Biosciences Total Liabilities (Quarterly): 8.284M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 8.284M |
September 30, 2022 | 10.70M |
June 30, 2022 | 10.31M |
March 31, 2022 | 53.37M |
December 31, 2021 | 56.37M |
September 30, 2021 | 15.55M |
June 30, 2021 | 14.85M |
March 31, 2021 | 16.50M |
December 31, 2020 | 23.22M |
September 30, 2020 | 25.11M |
June 30, 2020 | 21.64M |
March 31, 2020 | 22.01M |
December 31, 2019 | 26.34M |
September 30, 2019 | 25.66M |
June 30, 2019 | 26.99M |
March 31, 2019 | 25.93M |
December 31, 2018 | 16.01M |
September 30, 2018 | 11.76M |
Date | Value |
---|---|
June 30, 2018 | 11.81M |
March 31, 2018 | 30.72M |
December 31, 2017 | 42.15M |
September 30, 2017 | 47.45M |
June 30, 2017 | 51.62M |
March 31, 2017 | 58.18M |
December 31, 2016 | 4.89M |
September 30, 2016 | 5.113M |
June 30, 2016 | 5.01M |
March 31, 2016 | 4.294M |
December 31, 2015 | 3.962M |
September 30, 2015 | 5.935M |
June 30, 2015 | 4.434M |
March 31, 2015 | 3.769M |
December 31, 2014 | 4.404M |
September 30, 2014 | 74.66M |
June 30, 2014 | 6.416M |
December 31, 2013 | 55.66M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.284M
Minimum
Dec 2022
56.37M
Maximum
Dec 2021
23.79M
Average
22.01M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.68M |
Shareholders Equity (Quarterly) | 20.39M |